Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy

Status Completed

Clinical Trial Summary

The aim of this study is to compare early postoperative outcomes of unselected consecutive patients underwent laparoscopic cholecystectomy (LC) under spinal versus general anesthesia.

Clinical Trial Description

Laparoscopic cholecystectomy (LC) is the gold standard surgical treatment of symptomatic cholecystectomy which traditionally performed under general anesthesia. Laparoscopy has provided many advantages over open surgery for the patients; however, general anesthesia adversely affects patients' early postoperative quality of life (POQoL).

Spinal anesthesia which is a less invasive technique compared to general anesthesia has many advantages regarding the POQoL such as no need to wait for recovery from anesthesia, less nausea and vomiting, less or no pain at the end of surgery, no discomfort associated with intubation, early ambulation, fully awaken and oriented patient in the bed, and less anxious relatives.

LC has been shown to be feasible under spinal anesthesia if performed with proper technique. There are many reports demonstrated the effectiveness and safety of LC under spinal anesthesia in selected patients. However, patients with complicated gallstone disease such as acute, gangrenous or subacute cholecystitis have been considered as unfit cases for LC under spinal anesthesia because of technical difficulties. On the other hand, spinal anesthesia has also been regarded as inappropriate for patients complying with American society for anesthesiology (ASA) III and IV due to the uncontrolled anesthesia risks.

The aim of this study is to compare early postoperative outcomes of unselected consecutive patients underwent LC under spinal versus general anesthesia. If proportion of general anesthesia (PGA) / proportion of spinal anesthesia (PSA) denotes the proportion rate of outcomes in the general anesthesia group (GaG) / spinal anesthesia group (SaG), then two-sided test problem is assessed as follow:

1. Null hypothesis: H0: PGA = PSA. There is no difference between the two anesthesia techniques in terms of primary outcomes.

2. Null hypothesis: H1: PGA ≠ PSA There is a difference between the two anesthesia techniques in terms of primary outcomes. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02956252
Study type	Observational
Source	Medical Park Gaziantep Hospital
Contact
Status	Completed
Phase	N/A
Start date	June 2008
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03636841` - Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis	N/A
Completed	`NCT02379780` - Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy	N/A
Completed	`NCT01937104` - ONSD According to the Position During Laparoscopy	N/A
Completed	`NCT02264444` - Establishing Visualization Grading Scale on LESS Cholecystectomy	N/A
Completed	`NCT02461147` - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00746850` - Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis	N/A
Completed	`NCT00940264` - Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.	N/A
Completed	`NCT00370344` - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease	Phase 2/Phase 3
Completed	`NCT00195351` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection	Phase 4
Completed	`NCT02858986` - 3D Versus 4K Laparoscopic Cholecystectomy	N/A
Completed	`NCT04602156` - US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy	N/A
Completed	`NCT04942665` - Low Dose ICG for Biliary Tract and Tumor Imaging	Phase 2
Completed	`NCT02547064` - Effect of Modified Stylet Angulation on the Intubation With GlideScope®	N/A
Completed	`NCT00230971` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)	Phase 4
Completed	`NCT04122261` - A Clinical Study of Chinese Domestic Surgical Robot	N/A
Completed	`NCT04716166` - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	N/A
Completed	`NCT01476319` - Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department	N/A
Withdrawn	`NCT02225418` - Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy	N/A
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.